Yu Baofa Explained

Honorific Prefix:Dr.
Yu Baofa
Birth Place:Jinan, China
Nationality:Chinese
Education:Binzhou Medical College, Peking Union Medical College
Research Field:Intratumoral Cancer Therapy
Notable Works:Ultra Minimum Incision Personalized Intra-Tumoral Chemo-Immuno (UMIPIC) Therapy.

Yu Baofa (; born in 1958) is a Chinese oncologist and researcher in intratumoral cancer therapy and drug development.[1] He is the Founder, CEO and Chairman of Baofa Cancer Hospital Network China in Jinan, Beijing and Dongping.[2] He also developed Ultra Minimum Incision Personalized Intra-Tumoral Chemo-Immuno (UMIPIC) Therapy.[3] [4]

Early life and education

Yu was born in 1958 in Jinan, Shandong, China. During his childhood, the local doctors he saw in his village inspired him to become a physician in the future. He was educated in Binzhou Medical College. Four years later, he graduated and landed a job in the Shandong Tumor Research Institute and transferred to the China Academy of Medical Sciences for further studies in cancer.[1]

In 1984, his mother was diagnosed with esophageal cancer and later died. Soon after, his best friend's father died of cancer as well. These experiences motivated him to deepen his research of cancer.[1]

In 1985, Yu enrolled in Peking Union Medical College (tumour department) in Beijing to further his studies and received a master's degree of Medicine. After graduation, he worked at the China-Japan Friendship Hospital in Beijing for a year, before attending the School of Medicine of University of California, San Diego for doctoral studies.[1]

Career

Hospitals

Taimei Baofa Cancer Hospital was the first hospital established among three of Dr. Yu's hospitals. Since 1997, it has raised 38 million yuan (US$4.6 million). Yu also invited experts from Beijing and Jinan to offer training to his medical staff occasionally.[5]

His hospitals utilize various cancer treatments including surgery, radiotherapy, biological therapy, UMIPIC, as well as traditional Chinese medical treatments.[5]

Awards

Patents

Publications

External links

Notes and References

  1. Web site: Professor devoted to medical research and treatmentn . www.chinadaily.com.cn . 3 March 2019.
  2. Web site: Meet Dr. Baofa Yu . Baofa Immunotherapy, LLC. . 3 March 2019 . en.
  3. Yu . Baofa . Lu . Yuanfei . Gao . Feng . Jing . Peng . Wei . Han . Zhang . Peicheng . Liu . Guoliang . Ru . Ning . Cui . Guanghui . Xu . Xinhai . Sun . Chenglin . Guan . Changjiang . Che . Yebing . Wu . Yingli . Ma . Zhenlu . Fu . Qiang . Liu . Jian . Wang . Huan-You . Hapten-enhanced therapeutic effect in advanced stages of lung cancer by ultra-minimum incision personalized intratumoral chemoimmunotherapy therapy . Lung Cancer: Targets and Therapy. 6 . 1–11 . 10.2147/LCTT.S70679 . 28210146 . 5217516 . 2015 . free .
  4. Gao . Feng . Jing . Peng . Liu . Jian . Lu . Yuanfei . Zhang . Peicheng . Han . Wei . Liu . Guoliang . Ru . Ning . Cui . Guanghui . Sun . Chenglin . Che . Yebing . Zhang . Huaming . Hu . Qnglong . Wang . Huan-You . Wu . Yingli . Guan . Changjiang . Fu . Qiang . Ma . Zhenlu . Yu . Baofa . Hapten-enhanced overall survival time in advanced hepatocellular carcinoma by ultro-minimum incision personalized intratumoral chemoimmunotherapy . Journal of Hepatocellular Carcinoma. 2 . 57–68 . 10.2147/JHC.S80756 . 27508195 . 4918285 . 2015 . free .
  5. Web site: Hospital offers service to cancer patients chinadaily.com.cn. www.chinadaily.com.cn. 3 March 2019.
  6. Web site: China Youth Volunteer Action Contribution Award - Shandong Baofa Oncotherapy Corporation Limited. www.baofayiliao.com. 2019-03-06.
  7. Web site: Professor Yu Baofa won the first overseas Chinese "Outstanding Entrepreneurship Award" - Shandong Baofa Oncotherapy Corporation Limited. www.baofayiliao.com. 2019-03-06.

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Yu Baofa".

Except where otherwise indicated, Everything.Explained.Today is © Copyright 2009-2024, A B Cryer, All Rights Reserved. Cookie policy.